Sartorius

SRT · Xetra · EUR

€202.50Change from previous close: +1.55%Absolute change: +€3.10

Close · October 2, 2026

Company profile

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

Company facts

Industry
Medical Instruments & Supplies
Country
Germany
Headquarters
Otto-Brenner-Strasse 20, 37079, Göttingen
Employees
14,279
Listing
SRT · Xetra
Currency
EUR
ISIN
DE0007165607